Drug Shortage Report for GALANTAMINE ER
Report ID | 83018 |
Drug Identification Number | 02416573 |
Brand name | GALANTAMINE ER |
Common or Proper name | GALANTAMINE ER |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GALANTAMINE |
Strength(s) | 8MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-05-02 |
Estimated end date | Unknown |
Actual end date | 2023-07-10 |
Shortage status | Resolved |
Updated date | 2023-07-11 |
Company comments | Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-07-11 | French | Compare |
v4 | 2023-07-11 | English | Compare |
v3 | 2019-05-03 | English | Compare |
v2 | 2019-05-02 | French | Compare |
v1 | 2019-05-02 | English | Compare |
Showing 1 to 5 of 5